Bank Of Montreal Biogen Inc. Transaction History

Bank Of Montreal

$191 Billion
Q1 2024

A detailed history of Bank Of Montreal transactions in Biogen Inc. stock. As of the latest transaction made, Bank Of Montreal holds 236,815 shares of BIIB stock, worth $53.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

236,815

Previous 292,400 19.01%

Holding current value

$53.6 Million

Previous $75.7 Million 32.51%

% of portfolio

0.03%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$212.02 - $267.71 $11.8 Million - $14.9 Million	-55,585 Reduced 19.01%	236,815 $51.1 Million
Q4 2023 Feb 08, 2024	BUY	$222.59 - $267.94 $19 Million - $22.9 Million	85,557 Added 41.36%	292,400 $75.7 Million
Q3 2023 Nov 01, 2023	SELL	$253.3 - $285.89 $2.6 Million - $2.94 Million	-10,272 Reduced 4.73%	206,843 $53.2 Million
Q2 2023 Aug 02, 2023	SELL	$275.25 - $318.06 $29.4 Million - $33.9 Million	-106,692 Reduced 32.95%	217,115 $61.8 Million
Q1 2023 Jun 13, 2024	SELL	$256.56 - $292.34 $9.03 Million - $10.3 Million	-35,191 Reduced 14.86%	201,624 $56.1 Million

Q4 2022 Feb 01, 2023	BUY	$252.44 - $306.72 $11.2 Million - $13.7 Million	44,533 Added 15.95%	323,807 $89.7 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $9.86 Million - $13.6 Million	50,627 Added 22.14%	279,274 $75.7 Million
Q2 2022 Aug 11, 2022	BUY	$187.54 - $223.02 $11.7 Million - $13.9 Million	62,544 Added 37.65%	228,647 $56 Million
Q1 2022 May 12, 2022	SELL	$193.77 - $244.14 $21.8 Million - $27.5 Million	-112,577 Reduced 40.4%	166,103 $40.7 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $2.02 Million - $2.6 Million	-9,019 Reduced 3.13%	278,680 $68.3 Million
Q3 2021 Nov 12, 2021	BUY	$282.99 - $369.05 $26.9 Million - $35.1 Million	95,105 Added 49.38%	287,699 $91.7 Million
Q2 2021 Aug 12, 2021	BUY	$259.0 - $414.71 $49.9 Million - $79.9 Million	192,594 New	192,594 $79 Million

Others Institutions Holding BIIB

# of Institutions

1,046

Shares Held

126M

Call Options Held

1.37M

Put Options Held

1.35M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $32.6B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.

Account